India is the Antiviral Hub for Global Exporters – Know Why?
India is recognized for affordable, standard -quality drug exports.
It is the largest manufacturer and exporter of anti-retroviral drugs.
India procures about 70% of the generic HIV antiretroviral demand.
It supplies about 22% of generic hepatitis antiviral drugs.
Why is India the global market for antiviral drugs?
Indian manufacturers supply antiviral drugs to 200 + countries.
It is the leading and trusted supplier to international bodies like –
UNICEF and Médecins Sans Frontières
India leads the way due to –
- Low-cost production
- Advanced technology
- Large- scale generic manufacturing
The antiretroviral combinations exported from India-
- Abacavir 600mg/Lamivudine 300 mg Tablets- Abakast-L
- Lopinavir and Ritonavir USP Tablets- Lopinavir
- Tenofovir Disoproxil Fumurate, Emtricitabine & Efavirenz Tablets- Virarazer
The commonly exported Hepatitis B drugs-
- Entekor- 0.5- Entacavir 0.5mg tablets
- Tafnext – Tenofovir Alafenamide 25mg tablets
The commonly exported Hepatitis C medicines-
- Sofokast Plus- Daclatasvir and Sofosbuvir Tablets
- Ledikast- Ledipasvir & Sofosbuvir Tablets
The leading antiviral drug manufacturer/exporter from India-
Aprazer Healthcare is the top hepatology drug manufacturer.
We specialize in manufacturing –
- Hepatitis B medicines
- Hepatitis C medicines
- HIV medicines
We supply a wide range of antiviral drugs to 50 + countries.
Aprazer Healthcare is one of the leading antiviral drug exporters from India.
It is advised not to stop an antiviral drug regimen abruptly. Why?
Leaving antiviral treatment incomplete may lead to –
- Viral rebound/flare
- Drug resistance
- Treatment failure
Why is it important to check co-infections before taking antiviral drugs?
- To prevent severe liver flare-up
Treating one virus may activate the latent virus.
Taking Hepatitis C medicines with an undetected hepatitis B may cause hepatitis B reactivation.
- Avoid drug resistance –
Taking antiviral drugs in co-infection may lead to developing drug resistance.
Hepatitis B antivirals, when used in HIV co-infection, may lead to HIV drug resistance.
Though the drug is active against both viruses.
The dose may be lower to treat HIV.
HIV mutates to develop resistance against that drug.
- Managing immune reconstitution inflammatory syndrome –
The anti-retroviral drugs improve immune functions.
The active immune system detects the hidden infections.
This leads to a massive anti-inflammatory response.
- Prevent toxic drug interactions –
It helps prevent drug interactions.
Adding an antiviral drug regimen may disrupt how the liver processes medication.
Why choose Aprazer Healthcare for antiviral drug exports?
Aprazer Healthcare is the leading pharmaceutical company.
We manufacture a top range of antiviral products.
Our Anti-retroviral combinations are highly trusted and supplied globally.
Regulatory compliance –
We adhere to WHO-GMP/EU-GMP compliant manufacturing.
Assured Quality – We follow global quality parameters and in-house quality practices to ensure high-quality, safe products.
Reliable Supply chain network-
Partnering with authentic logistics, we have an integrated cold chain supply network.
Global reach – We supply antiviral drugs to countries in the Middle East, Asia, and Africa.
